Genomics England Limited

Overview

Legal name

GENOMICS ENGLAND LIMITED

Region

Unknown

Registered address

LEVEL 21 ONE CANADA SQUARE

CANADA SQUARE

LONDON

ENGLAND

E14 5AB

Insolvency history

Company events

Reference milestones and recent Companies House filing stream events.

7 events

01 May

2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec

2026

Accounts due

Accounts Due

Next accounts due date

17 Apr

2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

07 Apr

2026

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzUxNDc1MjMyMGFkaXF6a2N4

Published 07 Apr 2026 13:01

31 Mar

2025

Accounts filed

Accounts

Last accounts made up date

09 Oct

2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQzODg5MDA0OGFkaXF6a2N4

Published 09 Oct 2024 08:00

17 Apr

2013

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards

First funded

2019

Funded years

2019, 2021

Age at first award

6 years

Projects

2021 Collaborative R&D Lead participant

ISCF Supported whole genome sequencing in cancer trials

1 Jan 2021 to 31 Mar 2023

Awarded

£7,880,000

Total cost £7,880,000

2019 Collaborative R&D

DNA data management portal: Development of the tools, features and safeguards to ensure the public can access, understand, manage and share their digital genetic information online securely.

1 Oct 2019 to 31 Mar 2021

Awarded

£127,552

Total cost £127,552

"We are Sano Genetics, a leading developer of innovative digital health platforms, focussed on DNA and genetic sequencing and data. As the market for DNA sequencing - both public and private (£19.2bn by 2025;19% CAGR-[Allied Market Research][0]:2017) - continues to grow, as does the volume of personal health data stored. Whilst this opens up new opportuni...

Product types

Collaborative R&D